|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 405/14 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 31/4427 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3555064 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17817174.0 |
| Date of filing the European patent application | 2017-12-01 | |
| (97) | Date of publication of the European application | 2019-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-23 |
| (46) | Date of publication of the claims translation | 2023-01-10 |
| (86) | Number | PCT/IB2017/057577 |
| Date | 2017-12-01 |
| (87) | Number | WO 2018/109607 |
| Date | 2018-06-21 |
| (30) | Number | Date | Country code |
| 201662435533 P | 2016-12-16 | US |
| (72) |
ASPNES, Gary Erik , US
BAGLEY, Scott W. , US
CURTO, John M. , US
DOWLING, Matthew S. , US
EDMONDS, David James , US
FLANAGAN, Mark E. , US
FUTATSUGI, Kentaro , US
GRIFFITH, David A. , US
HUARD, Kim , US
INGLE, Gajendra , US
JIAO, Wenhua , US
LIMBERAKIS, Chris , US
MATHIOWETZ, Alan M. , US
PIOTROWSKI, David W. , US
RUGGERI, Roger B. , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | GLP-1 receptoriaus agonistai ir jų naudojimas |
| GLP-1 RECEPTOR AGONISTS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 8 | 185.00 EUR |
| 2025-12-01 |